|
Recent Developments |
|
31-JUL-17
Pfizer disclosed a steep drop in standalone net profit for the quarter ended June 2017. During the quarter, the profit of the company declined 28.57% to Rs 571.70 million from Rs 800.40 million in the same quarter previous year.
01-JUN-17
Pfizer has entered into an acquisition agreement with AstraZeneca AB, Sweden (AstraZeneca), pursuant to which the brand 'Neksium' is being acquired by the company in India for a consideration of Rs ... More.. |
| Business Profile |
Future Plans |
|
|
|
One To One
| Face To Face | | We would like to grow above the market and have a whole lot of strategies. We are looking at alliances, brands, lucrative products, line extensions, new delivery systems Kewal Handa ,finance director |
|
|
Recent news
|
|
|
| Period ending (months) | 31-Dec-2019(9) | 31-Mar-2019 (12) | 31-Mar-2018(12) | | Net sales | 16496.40 | 20815.00 | 14607.40 | | Other Income | 1388.00 | 1673.90 | 1142.90 | | Total Income | 17884.40 | 22488.90 | 15750.30 | | Cost of goods sold | -12678.50 | -15889.80 | 10989.50 | | OPBDIT | 30562.90 | 38378.70 | 4760.80 | | PAT | 4061.20 | 4290.50 | 2556.60 | | Gross Block | - | - | - | | Equity capital | - | 0.00 | 457.50 | | EPS (Rs.) | - | 0.00 | - | | DPS (Rs.) | - | - | - | | BV (Rs.) | - | - | - | | P/E range (x) | - | NA | - | | Debt / Equity (x) | - | - | - | | Operating margin (% of OI) | 170.9 | 170.7 | 30.2 | | Net margin (% of OI) | 22.7 | 19.1 | 16.2 |
|
|
Detailed Financials
|
|
|
|
|
